Abstract:As previously reported, we have synthesized an azo azomethine ligand 4-((E)-(2,5 dichloro phenyl) diazenyl)−2-((E)-((4-hydroxyphenyl) imine) methyl) phenol (L). The synthesized ligand has been used to prepare copper(II), nickel(II), and cobalt(II) metal complexes and characterized using various analysis techniques. To identify complexes, methods, such as elemental analyses, electrical conductivity, IR spectroscopy, mass spectrometry, magnetic moment, vibrating sample magnetometry (VSM), 1HNMR, UV–Vis, and thermal analysis were utilized, and a mononuclear structure was proposed for all compounds and all the complexes are non-electrolytes in nature. The chelation of the ligands to the metal ions occurs through phenolic oxygen and nitrogen atoms of the azomethine group of the ligands. According to various analytical and spectral data, a square planar structure is proposed for copper and nickel metal complexes and a quadrilateral structure is proposed for cobalt complexes. The antibacterial properties of ligands and complexes of copper(II), nickel(II), and cobalt(II) were investigated in vitro on standard bacteria as well as on bacteria isolated from clinical specimens (urine). The results revealed that the ligand and its metal complexes had a very high antibacterial activity against Staphylococcus aureus, but were ineffective against other studied bacteria. The synergistic effect of the compounds with the three antibiotics (vancomycin (V), methicillin (M), and trimethoprim (T)) was also investigated, along with the cytotoxicity of its ligand and copper complex in HFF cell line. At a concentration of 3.90 μl of these compounds, cell viability was significant. The structure of ligand and complexes was optimized by DFT calculations. Computational methods were performed for deeper understanding of the interaction between ligands and metal by EDA calculations. This result confirmed that the bonding between ligands to metal was mainly covalent. The complexes investigated are reported for the first time. The search for new antimicrobial agents against Staphylococcus aureus is an urgent medical need. Therefore, sensitive and selective diagnosis of this pathogenic bacterium is of great importance, which has been obtained in this study. The compounds synthesized from among the nine gram-negative and gram-positive bacteria are only sensitive to Staphylococcus aureus bacteria.

Co(II), Ni(II), Cu(II) and Zn(II) complexes of 1,8-naphthalimide-based ligand: syntheses, characterizations and evaluation of antibacterial activities

Synthesis, characterization and antioxidant, antibacterial activity Zn2+, Cu2+, Ni2+ and Co2+, complexes of ligand [2-(thiophen-2-yl)-1-(thiophen-2-ylmethyl)-1H-benzo[d]imidazole]

Synthesis, Structural Characterization, in Vitro Biological Activity, and Computational Quantum Chemical Studies of New Cobalt (II), Nickel (II), and Copper (II) Complexes Based on an Azo-Azomethine Ligand

Synthesis, spectral studies and antimicrobial evaluation of transition metal complexes of bidentate Schiff base ligands derived from 4-amino quinoline

Nickel(II), copper(II) and zinc(II) complexes containing symmetrical Tetradentate Schiff base ligand derived from 3,5-diiodosalicylaldehyde: Synthesis, characterization, crystal structure and antimicrobial activity

Synthesis, characterization and antibacterial study of Co(II), Ni(II), Zn(II) and Cu(II) complexes of methyl 2-{1-[(z)-3-methyl-5-oxo-1-phenyl-4,5- dihydro-1h-pyrazol-4-yl-idene]ethylamino}-3-phenylpropanoate

Spectroscopic, density functional theory and molecular docking studies of zinc (II) and nickel (II) complexes of N ˈ-(Furan-2-ylmethylene) furan-2-carbohydrazide as potential antibacterial drug

Synthesis, characterization and antibacterial activity of copper(ii) and nickel(ii) complexes with 3, 10-dialkyl-1, 3, 5, 8, 10, 12 hexaazacyclotetradecane ligand

Antibacterial, antifungal, DNA interactions, and antioxidant evaluation of Cu(II) Co(II), Ni(II), Mn(II) and UO2(II) mixed ligand metal complexes: Synthesis, characterization and molecular docking studies

A study of mononuclear 3d transition metal bis-Schiff base complexes: Synthesis, characterization, and evaluation of their antibacterial activity

Synthesis, Characterization,Computational Studies and Antimicrobial activity evaluation of Mixed ligand‐Metal complexes of selected thiosemicarbazones

Preparation, Characterization, DFT Calculations, Antibacterial and Molecular Docking Study of Co(II), Cu(II), and Zn(II) Mixed Ligand Complexes

Exploration of newly synthesized transition metal(II) complexes for infectious diseases

Synthesis, characterization, DFT computational studies and biological activity of transition metal complexes derived from 4-(((6-nitrobenzo[d]thiazol-2-yl)imino)methyl)benzene-1,3-diol

Synthesis and characterisation of phenanthroline-oxazine ligands and their Ag(I), Mn(II) and Cu(II) complexes and their evaluation as antibacterial agents

Manganese(II) and Zinc(II) metal complexes of novel bidentate formamide-based Schiff base ligand: synthesis, structural characterization, antioxidant, antibacterial, and in-silico molecular docking study

The Antibacterial Activity of Copper(II) and Nickel(II) Coordinated Compounds Containing a Polyaza Macrocyclic Ligand

Synthesis, characterization and biological relevance of Ni(II) and Fe(III) complexes of the halogenated 2,2′-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol) schiff base ligand

Synthesis, spectroscopic characterization, density functional theory calculations and biological evaluation of novel Cu(II) and Zn(II) Schiff base complexes as antimicrobial agents

Structure elucidation {single X-ray crystal diffraction studies, Hirshfeld surface analysis, DFT} and antibacterial studies of 1,2-benzothiazine metal complexes

Two Mononuclear Nickel(ii) Complexes with Schiff Base Ligands: Synthesis, Crystal Structures, and Antibacterial Activities